12:40 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our target price at $12, based on our DCF analysis. We update our 2025 adjusted loss per share (LPS) view to $0.02 (from an LPS of $0.99). We narrow our 2026 adjusted LPS estimate to $0.07 (from $0.91). After the mixed Q2 results, we maintain our Hold view on shares of TXG as we continue to see a number of uncertainties in the operating environment that the company has to navigate despite its commitment to innovation and market expansion. In Q2, headline sales figures were boosted by another significant patent litigation settlement, by $27M, and we raised our 2025 full year sales forecast to $626M (from $596M), while we lowered our Q4 revenue estimate to $155M (from $160M) as we expect the declining trend in instrument sales to persist. Due to high R&D expenses and increasing SG&A costs to support the growth of its business, TXG has a loss-making track record, which we continue to see as difficult to reverse in the 2025-2026 period.